Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-234-8 | CAS number: 234446-82-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study; evaluation of the in vitro protocol (EpiOcular) is in progress
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
- Principles of method if other than guideline:
- There are no official national or international guidelines for the EpiOcularTM test yet; however,
the study was performed according to the methods described in the following publications:
- MatTek Corporation, Ashland, MA 01721, USA: EpiOcularTM human cell construct:
Procedure details, Version 3.1a of February 10, 2010.
- Harbell J.W. et al. (2009): COLIPA Program on Optimization of Existing In Vitro Eye
Irritation Assays for Entry into Formal Validation: Technology Transfer and Intra/Inter
Laboratory Evaluation of EpiOcular Assay for Chemicals. Poster # 378, Society of
Toxicology, March 2009.
In addition the study follows the testing strategy for determination of eye irritation/corrosion
as given in the following OECD guideline:
- OECD Guideline for Testing of Chemicals No. 405, October 2, 2012 (“Acute Eye
Irritation/Corrosion”) - GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 13/0195-1
- IUPAC Name:
- 13/0195-1
- Reference substance name:
- Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)
- EC Number:
- 237-864-5
- EC Name:
- Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)
- Cas Number:
- 14025-15-1
- IUPAC Name:
- 14025-15-1
- Test material form:
- other: solid
- Details on test material:
- - Name of test material (as cited in study report): Test-substance No.: 13/0195-1
- Physical state: solid
- Analytical purity: The test substance is not fully characterized analytically.
- Lot/batch No.: 0008609840
Constituent 1
Constituent 2
Test animals / tissue source
- Species:
- other: in vitro test system (EpiOcularTM): reconstructed three dimensional human cornea model.
- Details on test animals or tissues and environmental conditions:
- CO2 incubator: Heraeus BBD 6220, Standard incubation conditions: about 37 °C, 5% CO2, 90-95 % humidity
Test system
- Vehicle:
- unchanged (no vehicle)
- Amount / concentration applied:
- 50 µL bulk volume (about 35 mg)
- Duration of treatment / exposure:
- 90 Minutes followed by a 18-hours post-incubation period
- Observation period (in vivo):
- not applicable (in vitro test)
- Number of animals or in vitro replicates:
- not applicable (in vitro test)
- Details on study design:
- The EpiOcularTM model (OCL-200) is a three-dimensional non-keratinized tissue construct composed of normal human derived epidermal keratinozytes used to model the human corneal epithelium.
Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colourimetric test.
Method:
1. Direct MTT reduction
To assess the ability of the test material to directly reduce MTT a pretest was performed. Thereby, the test substance was added to 0.9 mL of the MTT solution. The mixture was incubated in the dark at about 37 °C for 55 to 65 minutes. A negative control (de-ionized water) was tested concurrently.
If the MTT solution color or, in case of water-insoluble test substances the border to the water-phase, turned blue / purple, the test substance was presumed to directly reduce MTT.
2. Basic procedure:
Two EpiOcularTM tissues were incubated with the test substance, the PC or NC, respectively for 90 minutes.
CONTROLS
- Negative control (NC): 50 µL De-ionized water, sterile
- Positive control (PC): 50 µL methyl acetate
• Tissues were transferred to sterile plates with 1 mL assay medium and preconditioned at standard culture conditions for 16 – 24 hours (pre-incubation).
• Subsequently, the tissues were pre-treated with 20 μL of PBS and incubated at standard culture conditions for 30 minutes.
• Afterwards, the whole tissue surface was covered with a bulk volume of 50 µL of the undiluted test substance. After application, the tissues were incubated until the total exposure time of 90 minutes was completed.
• Tissues were washed with sterile PBS. After 12 minutes of post-soak immersion with medium, each tissue was dried on absorbent paper and transferred to fresh plates with pre-warmed medium. Subsequently, the tissues were incubated at standard culture conditions for 2 hours (post-incubation period).
• After the post-incubation period, the assay medium was replaced by MTT solution and the tissues were incubated for 3 hours. The formazan that was metabolically produced by the tissues was extracted by isopropanol and the optical density was determined spectrophotometrically at a wavelength of 570 nm (OD570) of the extracts.
Tissue viability: The quantification of tissue viability is presented as the quotient of the mean OD570 divided by the respective OD570 NC value in percent
ACCEPTANCE CRITERIA
In case one of the below given acceptance criteria is not covered, repetition of the test was considered.
- Assay acceptance criteria for the NC: Tissue viability is acceptable if the mean OD570 of the NC is ≥ 1.0<2.5.
- Acceptance criteria for the PC: A viability of < 50% is acceptable.
- Assay acceptance criteria for tissue variability: Two tissues were treated under the same conditions. Variability between the tissues is considered to be acceptable if the difference of the viability is ≤ 20%.
EVALUATION OF RESULTS
The irritation potential of the test materials is predicted from the mean relative tissue viabilities compared to the negative control tissues concurrently treated with sterile water. A chemical is considered as "irritant", if the mean relative tissue viability with a test material is less than or equal to 50%.
At present no prediction is performed if the mean relative tissue viability with a test material is > 50 ≤ 60% as the cut off value is currently being evaluated to lie in this range.
Results and discussion
In vivo
- Irritant / corrosive response data:
- The mean viability of the test-substance treated tissues was 89 %.
- Other effects:
- The test substance is able to reduce MTT directly. However, this ability of direct MTT reduction did not impair the study result as demonstrated by the concurrently performed exposure of control tissues inactivated by freezing.
Any other information on results incl. tables
EpiOcular Test (Summary of results)
Test substance |
Tissue 1 |
Tissue 2 |
Mean |
Inter-tissue variablilty (%) |
|
NC |
Mean OD570 |
1.836 |
1.700 |
1.768 |
|
Viability (% of NC) |
103.8 |
96.2 |
100 |
7.7 |
|
Test substance |
Mean OD570 |
1.593 |
1.539 |
1.566 |
|
Viability (% of NC) |
90.1 |
87.1 |
89 |
3.0 |
|
PC |
Mean OD570 |
0.347 |
0.239 |
0.306 |
|
Viability (% of NC) |
21.1 |
13.5 |
17 |
7.6 |
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information
- Conclusions:
- Based on the observed mean viability of 99% and applying the evaluation criteria, it was concluded that the test substance does not show an eye irritation potential in the EpiOcularTMeye irritation test under the test conditions chosen.
Based on this result classification for eye irritation is not warranted. - Executive summary:
The potential of Librel RMX 8 to cause ocular irritation was assessed by a single topical application of 50 μL bulk volume (about 35 mg) of the undiluted test substance to a reconstructed three dimensional human cornea model (EpiOcular™).
Two EpiOcular™ tissue samples were incubated with the test substance for 90 minutes followed by an 18-hours post-incubation period.
Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test. The reduction of mitochondrial dehydrogenase activity, measured by reduced formazan production after incubation with a
tetrazolium salt (MTT) was chosen as endpoint. The formazan production of the testsubstance treated epidermal tissues is compared to that of negative control tissues. The quotient of the values indicates the relative tissue viability.
The EpiOcular™ eye irritation test showed the following results:
The test substance is able to reduce MTT directly. However, this ability of direct MTT reduction did not impair the study result as demonstrated by the concurrently performed exposure of control tissues inactivated by freezing.
The mean viability of the test-substance treated tissues was 89 %.
Based on the observed results and applying the evaluation criteria it was concluded, that the test substance does not show an eye irritation potential in the EpiOcular™ eye irritation test under the test conditions chosen. (BASF 2013)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.